To fight another possible a wave of cases, “various tests are needed to ensure the safety of our employees and society, in order to find an exit strategy as quickly as possible,” SoftBank founder and CEO Masayoshi Son said during a live event on Tuesday. He warned that the vaccine against the virus may not be able to be mass-produced until “the middle of next year”.
A dozen such tests are currently being used or developed in the United States, for example, but few are very accurate. This means that they cannot detect the active virus, thus providing a false sense of security.
By then, the pandemic was already a devastation at Sona’s business. The collapse of travel and closure restrictions around the world has been catastrophic for many startups it has supported through its $ 100 billion Vision Fund. The fund suffered operating losses of nearly $ 18 billion for the fiscal year that ended in March, dragging SoftBank to its worst annual loss ever.